Invention Grant
- Patent Title: Methods of treating prader-willi syndrome with carbetocin
-
Application No.: US16938257Application Date: 2020-07-24
-
Publication No.: US10967040B2Publication Date: 2021-04-06
- Inventor: Mark C. Manning , Ryan E. Holcomb , Derrick S. Katayama , Christopher Bryant , Sara Cotter , Joseph William Cormier
- Applicant: Levo Therapeutics, Inc.
- Applicant Address: US IL Skokie
- Assignee: Levo Therapeutics, Inc.
- Current Assignee: Levo Therapeutics, Inc.
- Current Assignee Address: US IL Skokie
- Agency: Cooley LLP
- Main IPC: A61K38/12
- IPC: A61K38/12 ; C07K7/64 ; A61K38/095 ; A61K47/38 ; A61K47/55 ; A61K9/00 ; A61K9/08
Abstract:
The application describes stable aqueous compositions comprising relatively high concentrations of carbetocin and a solubilizer and/or surface active agent. The disclosed carbetocin compositions are effective in the treatment of a neurodevelopmental disorder, such as Präder-Willi syndrome. Additionally, the disclosed carbetocin compositions show improved stability at room temperature and/or under accelerated conditions of stress.
Information query
IPC分类:
